Temozolomide and interferon alpha 2b in metastatic melanoma stage IV. [electronic resource]
Producer: 20041019Description: 91-8 p. digitalISSN:- 0007-0963
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Dacarbazine -- administration & dosage
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Liver Neoplasms -- drug therapy
- Lung Neoplasms -- drug therapy
- Male
- Melanoma -- drug therapy
- Middle Aged
- Proportional Hazards Models
- Recombinant Proteins
- Remission Induction
- Skin Neoplasms -- drug therapy
- Survival Rate
- Temozolomide
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.